医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Promega 2016 Corporate Responsibility Report Highlights Initiatives Contributing to Purposeful Workplace

2016年08月16日 PM10:00
このエントリーをはてなブックマークに追加


 

MADISON, Wis.

The latest publication of the Promega Corporate Responsibility Report focuses on the organization’s thoughtful growth through expansion of energy-efficient facilities, advances in product development, continued community interactions and mindful development of employees. With continued growth, comes the ongoing goal to grow with purpose.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160816005201/en/

Promega 2016 Corporate Responsibility Report Highlights Initiatives Contributing to Purposeful Workp ...

Promega 2016 Corporate Responsibility Report Highlights Initiatives Contributing to Purposeful Workplace (Graphic: Business Wire)

Investing in the Future

As the expectations of society and needs of the customer change, Promega aspires to evolve with them. Corporate responsibility is a part of a foundation that supports the company’s future. Growth and long term planning in 2015 included investments in people, facilities, infrastructure, and products and services. Last fall, Promega Madison unveiled the Kepler Center which serves as our global supply chain center. In 2015, work began on renovations and expansions in California, UK, and Germany. Further investments in innovative research this last year resulted in 81 new patent filings, nearly 240 pending patents, as well as 21 new product launches in the past year.

Environmental Highlights

Promega is committed to environmental stewardship and aims to integrate the principles of sustainability across all aspects of our business, including the way we operate our facilities, transport products, and engage with customers. Since 2008, carbon emissions per building footprint has decreased 7% even with a 90% increase of high-energy intensive spaces. In 2015, we saw a reduction of 15% in water usage across the organization which saved 4 million gallons. For the future, goals have been set for environmental impact reductions in the areas of greenhouse gas emissions, electricity, natural gas, water, distribution emissions, and waste to be achieved by 2020.

Community Involvement

Promega focuses on positive interactions with our surrounding communities and cultivate relationships to help foster a strong community bond. Focusing on engagement and support in education, community wellness, and creativity helps to enrich the lives of those around us. Globally, Promega employees remain involved in their local communities in ways that fit the unique needs of their region. The diverse organizations supported in 2015 are disclosed in more detail in the report.

For more than 30 years, Promega has integrated the values of corporate responsibility and sustainable business practices into corporate culture and activity. The 2016 Corporate Responsibility Report continues to show how Promega aligns business practices with positive social, environmental and business outcomes.

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 3,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160816005201/en/

CONTACT

Promega Corporation
Penny Patterson
Sr. Director,
Communications
Phone: (608) 274-4330
E-mail: penny.patterson@promega.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表